Prescription drug price transparency
The following resources are for reporting entities who may need assistance with prescription drug price transparency.
On this page
Want to stay up-to-date on prescription drug price transparency?
Reporting entity resources (carriers, manufacturers, PBMs, PSAOs)
The following resources are for reporting entities who may need assistance.
The excel templates below are available as an aid if you are hand-keying data for submissions to the Drug Price Transparency program. These workbooks are programmed with simple rules that will help you avoid some common errors that can occur.
Important note about Excel version
We recommend using Microsoft Excel 2016 or earlier for the submission guides. Using Microsoft Excel 2019 can cause formatting issues when saving as a CSV file.
DPT login process
Starting November 15, reporting entities can log into HCA Support to enter their data for the DPT program. You will need a SecureAccess Washington (SAW) account to login.
Setting up a SAW account
Step-by-step instructions for accessing DPT reporting forms
Extensions
Use the extension form if you are not able to meet the due date of a required report and would like to request additional time. To access the extension form, follow the instructions for accessing DPT reporting forms. Once you have accessed the portal, you will see the DPT re-submission/extension option.
All
- Data submission FAQ (updated 12/1/2021)
Carriers
Report year 2023 (effective September 1, 2024)
- Change summary
- Data submission guide
- Cost utilization template
- Premium impact template
- Specialty drug list template
Manufacturers
Report year 2025 (effective February 1, 2025)
- Change summary
- Data submission guide
- Price increase template
- New covered drugs template
- New drugs template
Pharmacy Benefit Managers (PBM)
Report year 2023 (due date March 1, 2025)
Pharmacy Services Administrative Organizations (PSAO)
Report year 2023 (effective September 1, 2024)
- Change summary
- Data submission guide
- Pharmacy benefit manager contracted rates template
- Pharmacy benefit manager year-over-year rate change template
- Pharmacy contracted rates template
- Pharmacy year-over-year rate change template
Stakeholder meetings
At each meeting, HCA will give a short overview of Chapter 43.71C RCW then use the majority of time to take questions and hear concerns from stakeholders. We will focus on a different supplier in each meeting. The public is invited to participate in any of the meetings.
Meeting schedule
| Date and time | Meeting type | Materials |
|---|---|---|
| July 28, 2021 | PBM listening session | |
| July 22, 2021 | Manufacturer listening session | |
| July 6, 2021 | Carrier listening session | |
| April 29, 2020 |
Pharmacy benefit manager / pharmacy service administrative organization reporting Webinar only, no in person meeting due to COVID-19 |
|
| April 1, 2020 |
Issuer / carrier reporting Webinar only, no in person meeting due to COVID-19 |
Updated slide deck |
| February 26, 2020 | Manufacturer reporting |
Background
In 2019, the Washington State Legislature passed Engrossed Second Substitute House Bill into law. This law requires issuers of health insurance, pharmacy benefit managers (PBMs), manufacturers, and pharmacy service administrative organizations (PSAOs) to submit data to the Health Care Authority (HCA). The purpose is to create an annual report on how prescription drugs affect health care costs. The law also requires pharmaceutical manufacturers to submit data to HCA relating the new drug applications (NDA).
Reports
Annual reports created by HCA to detail the current state of the program as the agency begins to receive drug pricing and cost data.